Novel bioactivation pathway of benzbromarone mediated by cytochrome P450

Yumina Kitagawara, Tomoyuki Ohe, Kumiko Tachibana, Kyoko Takahashi, Shigeo Nakamura, Tadahiko Mashino

研究成果: Article

10 引用 (Scopus)


Benzbromarone (BBR) is a hepatotoxic drug, but the detailed mechanism of its toxicity remains unknown. We identified 2,6-dibromohydroquinone (DBH) and mono-debrominated catechol (2-ethyl-3-(3-bromo-4,5-dihydroxybenzoyl) benzofuran; CAT) as novel metabolites of BBR in rat and human liver microsomal systems by comparison with chemically synthesized authentic compounds, and we also elucidated that DBH is formed by cytochrome P450 2C9 and that CAT is formed mainly by CYP1A1, 2D6, 2E1, and 3A4. Furthermore, CAT, DBH, and the oxidized form of DBH are highly cytotoxic in HepG2 compared with BBR. Taken together, our data demonstrate that DBH, a novel reactive metabolite, may be relevant to BBR-induced hepatotoxicity.

ジャーナルDrug Metabolism and Disposition
出版物ステータスPublished - 2015 9 1

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science

フィンガープリント Novel bioactivation pathway of benzbromarone mediated by cytochrome P450' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用